| Literature DB >> 28585054 |
H K Svensson1,2,3, L-E Olsson4,5,6, T Hansson6, J Karlsson6, E Hansson-Olofsson4,5,6.
Abstract
Vertebral compression fracture (VCF) is a common fragility fracture and the starting point of a lasting, painful, disabling condition. The aim was to summarize evidence of person-centered/non-medical interventions supporting women with VCF. Results show small numbers of studies with only probable effect on function, pain, QoL, fear of falling, and psychological symptoms. The vertebral compression fracture (VCF) caused by osteoporosis is the third most common fragility fracture worldwide. Previously, it was believed that the pain caused by VCF was self-subsiding within weeks or a few months post-fracture. However, this positive prognosis has been refuted by studies showing that, for the great majority of patients, the VCF was the starting point of a long-lasting, severely painful, and disabling condition. The low number of studies focusing on the experience of the natural course of VCF, and what support is available and how it is perceived by those affected, calls for further investigation. Strengthening older patients' sense of security and increasing confidence in their own abilities are of great importance for successful rehabilitation following VCF. More research is needed to identify resources, possibilities, and strategies that can assist older patients to reach their goals to improve well-being. The purpose of this systematic review was to identify and summarize the current evidence of person-centered or other structured non-medical/non-surgical interventions supporting older women after experiencing an osteoporotic VCF. A systematic literature search was conducted on the MeSH terms encompassing osteoporosis and vertebral compression fractures in the PubMed-MEDLINE and Cumulative Index for Nursing and Allied Health Literature (CINAHL) databases during March through June 2015. The initial search identified 8789 articles, but only seven articles (six randomized controlled trials and one observational study with a control group) met the inclusion criteria. It became evident from the current study that the availability of evidence on the effects of non-medical interventions aiming to support older women with VCF is limited, to say the least. The trials included in this review have few limitations and were mainly considered to be of moderate quality. This systematic literature review suggests that non-medical interventions aiming to support older women with VCF might decrease levels of pain and use of analgesic as well as promote improved physical mobility and function. These interventions would probably result in an improved difference in experiences of fear of falling and perceived psychological symptoms, but would only slightly improve quality of life. However, given the nature of the seven studies, potential biases in patient selection, issues around precision with small cohorts, and failure to control for confounders, makes it difficult to draw a definitive conclusion about the significant effects of non-medical interventions. Incurring a VCF is a complex and diverse event, necessitating equally complex interventions to identify new ways forward. However, to date, interventions struggle with a risk of selection bias in that only the needs of the healthiest of the population are addressed and the voices of the remaining majority of the people affected by VCF are unheard.Entities:
Keywords: Nursing; Osteoporotic vertebral compression fracture; Supportive interventions
Mesh:
Year: 2017 PMID: 28585054 PMCID: PMC5550548 DOI: 10.1007/s00198-017-4099-8
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507
PICO
| P | Women, ≥65 years, living with osteoporosis and one or several vertebral compression fractures |
| I1 | Person-centered interventions |
| I2 | Other supporting interventions |
| C | Conventional treatment |
| O | Primary—pain, quality of life, fear of falling, social and physical isolation |
| S | RCT and observational studies |
Fig. 1PRISMA-flow chart
Excluded publications
| First author | Year/country | Reason for exclusion |
|---|---|---|
| Barker K. L. et al. [ | 2014 UK | Design and study protocol |
| Bennell K. L. et al. [ | 2010 Australia | Population of both men and women |
| Ekström H. et al. [ | 2013 Sweden | Multiple fractures included |
| Giangregorio L. M. et al. [ | 2014 Canada | Recommendations |
| Giangregorio L. M. et al. [ | 2013 Canada | Review |
| Gran Kronhed A. C. et al. [ | 2009 Sweden | Exclusively osteoporosis |
| Hall S. E. et al. [ | 1999 Australia | No intervention |
| Hongo M. et al. [ | 2006 Japan | Exclusively osteoporosis |
| Hoshino M. et al. [ | 2013 Japan | Population of both men and women |
| Hübscher M. et al. [ | 2010 Germany | Descriptive |
| Kaffashian S. et al. [ | 2011 France | Compilation of health-related costs |
| Kammerlander C. et al. [ | 2014 Austria | Epidemiology and screening |
| Klazen C. A. et al. [ | 2010 Netherlands | Descriptive |
| Lukert B. P. et al. [ | 1994 USA | Recommendations of pain relief |
| Majumdar S. R. [ | 2012 Canada | Intervention targeting treatment compliance |
| Papa J. A. [ | 2012 Canada | Descriptive |
| Pratelli E. et al. [ | 2010 Italy | Recommendations |
| Riccio I. et al. [ | 2013 Italy | Recommendations |
| Schröder G. et al. [ | 2012 Germany | Exclusively osteoporosis |
| Suzuki N. et al. [ | 2008 Japan/Sweden | Descriptive |
| Suzuki N. et al. [ | 2009 Japan/Sweden | Descriptive |
| Suzuki N. et al. [ | 2010 Japan/Sweden | Descriptive |
| Varacallo M. A. [ | 2014 USA | Medical treatment |
| Venmans A. et al. [ | 2014 Netherlands | Descriptive pain |
| Wang L. Y. et al. [ | 2013 Taiwan | Descriptive balance |
| Yoon S. P. et al. [ | 2014 Korea | Descriptive |
Characteristics of included publications
| Authors | Year | Country | Patients | Mean age (year) | Study design | Study duration | Outcome variables | Intervention vs control | Discontinuation |
|---|---|---|---|---|---|---|---|---|---|
| Olsen C.F. & Bergland A. [ | 2014 | Norway | IT, 47; | 71.1 | RCT | 12 months | P, mobility; | Exercise program 60 min/3 months vs. maintaining current exercise | IT, 19% (9) discontinued; |
| Papaioannou A., Adachi J. D., Winegard K., Ferko N., Parkinson, W., Cook, R J., Webber, C & McCartney N. [ | 2003 | Canada | IT, 37; | 71.6 | RCT | 12 months | P, QoL; | Home-based exercise program 60 min 3 days/week 6 months vs. maintaining current exercise | CT + IT, 19% (14) discontinued 6 months; |
| Gold D.T., Shipp K.M., Pieper C.F., Duncan P. W., Martinez S. & Lyles K.W. [ | 2004 | USA | IT, 94; | 81 | RCT/cross-over | 12 months (6 + 6 months) | P, trunk extension; | Exercise and coping classes 45 min 2 times/week 6 months vs. health education 6 months | IT, 10% (9) discontinued phase 1; |
| Bergland A., Thorsen H. & Kåresen R. [ | 2011 | Norway | IT, 47; | 71.4 | RCT | 12 months | P, mobility (walking speed); | Circuit exercise and coping class 1 h 2 times/week in 3 months vs. maintaining current lifestyle | IT, 20% (9) discontinued; |
| Malmros B., Mortensen L., Jensen M. B. & Charles P. [ | 1998 | Denmark | IT, 27; | IT, 65; | RCT | 22 weeks | Pain, | Physiotherapeutic training 2 times/week 10 weeks vs. no training | IT, 11% (3) discontinued; |
| Zambito A., Bianchini D., Gatti D., Rossini M., Adami S. & Viapiana O. [ | 2007 | Italy | HT, 35; | IFT, 70.8; | RCT | 14 weeks | P, chronic low back pain | IFT therapy vs. HT therapy vs. sham HT therapy | HT (35) + IFT (35) + HT sham (35) 0% discontinued |
| Kessenich C.R., Guyatt G.H., Patton C.L., Griffith., Hamlin A. & Rosen C.J. [ | 2000 | USA | IT, 25; | IT, 71.7; | Observational study/cross sectional | 8 weeks | P, QoL | Support and educational group 90 min 1 time/week in 8 weeks vs. usual clinical care | IT, 0% discontinued; |
Assessment of risk of bias
| Selection bias | Performance bias | Assessment bias | Attrition bias | Reporting bias | |
|---|---|---|---|---|---|
| Olsen 2014 | + | + | + | + | ? |
| Papaioannou 2003 | + | ? | + | + | + |
| Gold 2004 | + | + | + | + | ? |
| Bergland 2011 | + | + | + | + | + |
| Malmros 1998 | ? | + | ? | ? | + |
| Zambito 2007 | + | ? | + | + | + |
| Kessenich 2000 | - | + | ? | + | + |
? unclear risk, + low risk, - high risk
Outcome physical mobility
| Measurements | Intervention | Control | Comments | |
|---|---|---|---|---|
| Physical mobility | ||||
| Olsen et al. 2014 | Maximum walking speed | 3 months, | 3 months, | • Participants and administrator of the intervention was not blinded for allocation, but this is difficult given the nature of the intervention. |
| 12 months, | 12 months, | |||
| Functional reach (cm) | 3 months, | 3 months, | ||
| 12 months, | 12 months, | |||
| Papaioannou et al. 2003 [ | OQLQ (physical function) | 6 months, | • In the section on describing the management of the participants, it is unclear whether they or the practitioners were blinded or not, which may not be possible considering the nature of the intervention. | |
| 12 months, | ||||
| Stance test (balance) | 6 months, | |||
| Time up and go (function) | 6 months, | |||
| Gold et al. 2004 [ | Trunk extension | Phase 1, | Phase 1, | • The assessment tool for trunk extension can be seen as sensitive to assessment bias due to its nature. |
| Phase 2, | Phase 2, | |||
| Bergland et al. 2011 [ | Maximum walking speed | 3 months, | 3 months, | • The process of randomization was implemented with a block of 8, for which the purpose is not stated. |
| 12 months, | 12 months, | |||
| Time up and go (sec/min sitting-walk 3 m-sitting) | 3 months, | 3 months, | ||
| 12 months, | 12 months, | |||
| Functional reach (cm) | 3 months, | 3 months, | ||
| 12 months, | 12 months, | |||
| Qualeffo-41 physical function | 3 months, | 3 months, | ||
| 12 months, | 12 months, | |||
| Malmros et al. 1998 [ | Daily level of function (Oswestry questionnaire) | 10 weeks, | 10 weeks, | • There is a low risk of selection bias, but an explanation for using block limitation of 12 is not described. |
| 22 weeks, | 22 weeks, | |||
| Balance (Chattecx balance system) | 5 weeks, | 5 weeks, | ||
| 10 weeks, | 10 weeks, | |||
| Arm strength (kg) | 5 weeks, | 5 weeks, | ||
| 10 weeks, | 10 weeks, | |||
Outcome pain
| Measurements | Intervention | Control | Comments | |
|---|---|---|---|---|
| Pain | ||||
| Malmros et al. 1998 [ | Pain level (range 0–10) | 5 weeks, | 5 weeks, | • The use of PP or ITT was not described |
| 10/22 weeks, | 10/22 weeks, | |||
| Use of analgesic (0–20; 20=no analgesic) | 5 weeks, | 5 weeks, | ||
| 10/22 weeks, | 10/22 weeks, | |||
| Gold et al. 2004 [ | Pain with activity FSI (range 1–4) | Phase 1, | Phase 1, | • An in-advance published study protocol is missing and chosen outcomes cannot be audited. |
| Phase 2, | Phase 2, −0.03 | |||
| Zambito et al. 2007 | Pain score (VAS) (range 0–10) | 2 weeks, | 2 weeks, | • The randomize process is well described but without but without any given explanation to the block limitation. |
| 6 weeks, | 6 weeks, | |||
| 14 weeks, | 14 weeks, | |||
| Backhill (range 0–40) | 2 weeks, | 2 weeks, | ||
| 6 weeks, | 6 weeks, | |||
| 14 weeks, | 14 weeks, | |||
Outcome quality of life
| Measurements | Intervention | Control | Comments | |
|---|---|---|---|---|
| Quality of life | ||||
| Bergland et al. 2011 [ | GHQ-20 (range 0–3) | 3 months, | 3 months, | • There is no description of how the authors balanced baseline variables, even though the discontinuation was small. |
| 12 months, | 12 months, | |||
| QUALEFFO-41 total (range 0–100) | 3 months, | 3 months, | ||
| 12 months, | 12 months, | |||
| Papaioannou et al. 2003 [ | OQLQ (mean changes) (range1–7) | Between groups | • It is unclear whether they or the practitioners were blinded or not, which may not be possible considering the nature of the intervention. | |
| Emotion, | ||||
| Leisure/social, | ||||
| SIP (mean changes) (range 0–68) | 6 months, | |||
| Kessenich et al. 2000 [ | Cantril ladder (range 0–10, mean changes) | 8 weeks, | 8 weeks, | • In this study, there is a high risk for selection bias since the participants were allocated through own preferences. This will contribute to a difference between groups at baseline, perhaps not in demographic data but on level of motivation and physical function. |
| SF-36 (physical) (range 0–100, mean change) | 8 weeks, | 8 weeks, | ||
| SF-36 (mental) (range 0–100, mean changes) | 8 weeks, | 8 weeks, | ||
| OQLQ (range 1–7, mean changes) | 8 weeks, | 8 weeks, | ||
| Emotion, | Emotion, | |||
| Leisure/social, | Leisure/social, | |||
| Malmros et al. 1998 [ | QoL (own questionnaire) (range 0–20) | 5 weeks, | 5 weeks, | • An in-advance published study protocol was not described and which outcomes were primary or secondary is unclear. |
| 10 weeks, | 10 weeks, | |||
| 22 weeks, | 22 weeks, | |||
Outcome fear of falling
| Measurements | Intervention | Control | Comments | |
|---|---|---|---|---|
| Fear of falling | ||||
| Olsen et al. 2014 | FES-1 (range 16–64 (1–4), mean change) | 3 months, | 3 months, | • Participants and administrator of the intervention was not blinded for allocation, but this is difficult given the nature of the intervention. |
| 12 months, | 12 months, | |||
Outcome psychological symptoms
| Measurements | Intervention | Control | Comments | |
|---|---|---|---|---|
| Psychological symptoms | ||||
| Gold et al. 2004 [ | Psychological symptoms GSI (range 0–4) | Phase 1, | Phase 1, | • Participants and administrator of the intervention was not blinded for allocation, but this is difficult given the nature of the intervention. |
| Phase 2, | Phase 2, | |||